Press Releases

May 09, 2019

Veracyte to Present at the UBS Global Healthcare Conference

Read More

May 07, 2019

Veracyte Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Read More

May 02, 2019

Veracyte Announces Pricing of Public Offering of 5,500,000 Shares of Common Stock

Read More

May 01, 2019

Veracyte Announces Proposed Public Offering of Common Stock

Read More

Apr 30, 2019

Veracyte Announces First Quarter 2019 Financial Results

Read More

Apr 22, 2019

Veracyte Receives Regulatory Authorization to Offer Envisia Genomic Classifier for Patients in New York State

Read More

Apr 22, 2019

Veracyte Names Alfred Bowie, Jr., Ph.D. as Vice President, Corporate and Business Development

Read More

Apr 08, 2019

Veracyte Announces Publication Highlighting Afirma GSC’s Ability to Rule Out Cancer in Challenging Thyroid Nodule Subtype

Read More

Apr 03, 2019

Veracyte to Release First Quarter 2019 Financial Results on April 30, 2019

Read More

Apr 01, 2019

Veracyte Announces Data Published in The Lancet Respiratory Medicine Demonstrate that the Envisia Genomic Classifier Improves Diagnosis of IPF

Read More